In its most recent SEC filing, Meritage Portfolio Management reduced its position in JPMorgan Chase & Co. by 8.7% during the third quarter, selling 5,129 shares to hold 53,824 shares at quarter end. Those shares represented 1.1% of Meritage’s portfolio and ranked JPMorgan as its 12th largest holding. At the end of the period, the position was valued at approximately $17 million, reflecting the firm’s confidence in reallocating capital while still maintaining a meaningful investment in the largest U.S. bank by assets.

Several smaller hedge funds either initiated or adjusted positions in JPMorgan Chase during the second and third quarters. Harbor Asset Planning initiated a new stake worth $26,000, while Mizuho Securities increased its holding by 450%, acquiring 90 additional shares. Mountain Hill Investment Partners and Family Legacy Financial each built new or expanded positions of roughly $32,000 to $33,000. Meanwhile, Clarity Asset Management lifted its stake by 87.1%, adding 101 shares worth $63,000. Collectively, institutional and hedge fund ownership remains elevated at 71.55%, underscoring broad professional investor interest in the bank’s diversified revenue streams.

On January 13, JPMorgan Chase reported quarterly earnings per share of $5.23, surpassing consensus estimates by $0.30, driven by a 7.1% year-over-year revenue increase to $46.8 billion. Return on equity reached 17.16% and net margin 20.35%, while analysts project full-year EPS of 18.1. In conjunction with earnings, the firm declared a quarterly dividend of $1.50 per share, up from prior payouts, reflecting a 30% payout ratio and yielding 2.0% on an annualized basis. The dividend will be paid at the end of January to shareholders of record as of early January.

During the last quarter, insiders sold a total of 15,834 shares valued at nearly $5 million. Notably, General Counsel Stacey Friedman and COO Jennifer Piepszak reduced their holdings by 4.95% and 10.77% respectively through transactions disclosed in SEC filings. On the research front, fourteen analysts maintain Buy ratings while thirteen hold the stock, with consensus target estimates in the mid-$330 range. Recent upgrades by Piper Sandler and Morgan Stanley reflect confidence in continued net interest income growth and capital returns, even as a handful of peers have moderated to Hold ratings based on valuation considerations.